Matthew J Cummings1, Barnabas Bakamutumaho2, John Kayiwa2, Timothy Byaruhanga2, Nicholas Owor2, Barbara Namagambo2, Allison Wolf3, Joseph F Wamala4,5, Stephen S Morse6, Julius J Lutwama2, Max R O'Donnell3,6. 1. 1 Department of Medicine and. 2. 2 National Influenza Center, Uganda Virus Research Institute, Entebbe, Uganda. 3. 3 Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, New York. 4. 4 Epidemiology and Surveillance Division, Ministry of Health, Kampala, Uganda. 5. 5 South Sudan Country Office, World Health Organization, Juba, South Sudan; and. 6. 6 Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
Abstract
RATIONALE: Little is known about the epidemiology of severe acute respiratory infection (SARI) or influenza in sub-Saharan Africa. Characterization of influenza transmission dynamics and risk factors for severe disease and mortality is critical to inform prevention and mitigation strategies. OBJECTIVES: To characterize the epidemiology and transmission dynamics of influenza and risk factors for influenza-associated severe respiratory infection in Uganda. METHODS: Clinicians at 12 sentinel surveillance sites prospectively collected clinical data and upper respiratory tract samples from consecutive patients who met criteria for SARI and influenza-like illness (ILI). Samples were tested for influenza A and B viruses using real-time reverse transcription-polymerase chain reaction. Spatial and spatiotemporal cluster modeling was performed to identify loci of increased influenza transmission. Morbidity and mortality were assessed through chart review in a defined subset of patients. Univariable and multivariable analyses were used to identify risk factors for severe respiratory infection, prolonged hospitalization, and in-hospital mortality. MEASUREMENTS AND MAIN RESULTS: From October 2010 to June 2015, 9,978 patients met case definitions for SARI and ILI and had samples tested for influenza A and B. Of the 9,978 patient samples tested, 1,113 (11.2%) were positive for influenza. Among 6,057 patients with ILI, 778 samples (12.8%) were positive, and among 3,921 patients with SARI, 335 samples (8.5%) were positive. Significant clustering of influenza cases was observed in urban and periurban areas and during rainy seasons. Among 1,405 cases of SARI with available outcome data, in-hospital mortality was 1.6%. Infection with the 2009 pandemic A/H1N1 subtype and prolonged time to presentation were independently associated with SARI among influenza cases. CONCLUSIONS: Influenza is associated with a substantial proportion of acute respiratory infection in Uganda. As influenza vaccination programs are developed in East Africa, timing campaigns to confer protection during rainy seasons should be considered, particularly among high-risk urban populations.
RATIONALE: Little is known about the epidemiology of severe acute respiratory infection (SARI) or influenza in sub-Saharan Africa. Characterization of influenza transmission dynamics and risk factors for severe disease and mortality is critical to inform prevention and mitigation strategies. OBJECTIVES: To characterize the epidemiology and transmission dynamics of influenza and risk factors for influenza-associated severe respiratory infection in Uganda. METHODS: Clinicians at 12 sentinel surveillance sites prospectively collected clinical data and upper respiratory tract samples from consecutive patients who met criteria for SARI and influenza-like illness (ILI). Samples were tested for influenza A and B viruses using real-time reverse transcription-polymerase chain reaction. Spatial and spatiotemporal cluster modeling was performed to identify loci of increased influenza transmission. Morbidity and mortality were assessed through chart review in a defined subset of patients. Univariable and multivariable analyses were used to identify risk factors for severe respiratory infection, prolonged hospitalization, and in-hospital mortality. MEASUREMENTS AND MAIN RESULTS: From October 2010 to June 2015, 9,978 patients met case definitions for SARI and ILI and had samples tested for influenza A and B. Of the 9,978 patient samples tested, 1,113 (11.2%) were positive for influenza. Among 6,057 patients with ILI, 778 samples (12.8%) were positive, and among 3,921 patients with SARI, 335 samples (8.5%) were positive. Significant clustering of influenza cases was observed in urban and periurban areas and during rainy seasons. Among 1,405 cases of SARI with available outcome data, in-hospital mortality was 1.6%. Infection with the 2009 pandemic A/H1N1 subtype and prolonged time to presentation were independently associated with SARI among influenza cases. CONCLUSIONS: Influenza is associated with a substantial proportion of acute respiratory infection in Uganda. As influenza vaccination programs are developed in East Africa, timing campaigns to confer protection during rainy seasons should be considered, particularly among high-risk urban populations.
Entities:
Keywords:
Africa South of the Sahara; acute respiratory infection; epidemiology; influenza; spatiotemporal analysis
Authors: Shannon S Carson; Robert A Fowler; J Perren Cobb; Yaseen M Arabi; David H Ingbar Journal: Am J Respir Crit Care Med Date: 2015-04-01 Impact factor: 21.405
Authors: James Tamerius; Martha I Nelson; Steven Z Zhou; Cécile Viboud; Mark A Miller; Wladimir J Alonso Journal: Environ Health Perspect Date: 2010-11-19 Impact factor: 9.031
Authors: Wan Yang; Matthew J Cummings; Barnabas Bakamutumaho; John Kayiwa; Nicholas Owor; Barbara Namagambo; Timothy Byaruhanga; Julius J Lutwama; Max R O'Donnell; Jeffrey Shaman Journal: Epidemics Date: 2018-03-19 Impact factor: 4.396
Authors: Matthew J Cummings; Barnabas Bakamutumaho; Wan Yang; Joseph F Wamala; John Kayiwa; Nicholas Owor; Barbara Namagambo; Timothy Byaruhanga; Allison Wolf; Julius J Lutwama; Jeffrey Shaman; Max R O'Donnell Journal: Am J Trop Med Hyg Date: 2018-01-01 Impact factor: 2.345
Authors: Wan Yang; Matthew J Cummings; Barnabas Bakamutumaho; John Kayiwa; Nicholas Owor; Barbara Namagambo; Timothy Byaruhanga; Julius J Lutwama; Max R O'Donnell; Jeffrey Shaman Journal: Influenza Other Respir Viruses Date: 2018-04-17 Impact factor: 4.380
Authors: Matthew J Cummings; Rafal Tokarz; Barnabas Bakamutumaho; John Kayiwa; Timothy Byaruhanga; Nicholas Owor; Barbara Namagambo; Allison Wolf; Barun Mathema; Julius J Lutwama; Neil W Schluger; W Ian Lipkin; Max R O'Donnell Journal: Clin Infect Dis Date: 2019-03-19 Impact factor: 9.079
Authors: Melissa Emery Thompson; Zarin P Machanda; Erik J Scully; Drew K Enigk; Emily Otali; Martin N Muller; Tony L Goldberg; Colin A Chapman; Richard W Wrangham Journal: R Soc Open Sci Date: 2018-09-19 Impact factor: 3.653